1. Home
  2. NYXH vs SAR Comparison

NYXH vs SAR Comparison

Compare NYXH & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYXH
  • SAR
  • Stock Information
  • Founded
  • NYXH 2009
  • SAR 2007
  • Country
  • NYXH Belgium
  • SAR United States
  • Employees
  • NYXH N/A
  • SAR N/A
  • Industry
  • NYXH Medical/Dental Instruments
  • SAR Investment Managers
  • Sector
  • NYXH Health Care
  • SAR Finance
  • Exchange
  • NYXH Nasdaq
  • SAR Nasdaq
  • Market Cap
  • NYXH 394.1M
  • SAR 341.0M
  • IPO Year
  • NYXH 2021
  • SAR 2007
  • Fundamental
  • Price
  • NYXH $10.35
  • SAR $25.97
  • Analyst Decision
  • NYXH Strong Buy
  • SAR Buy
  • Analyst Count
  • NYXH 5
  • SAR 4
  • Target Price
  • NYXH $17.00
  • SAR $25.08
  • AVG Volume (30 Days)
  • NYXH 30.4K
  • SAR 145.0K
  • Earning Date
  • NYXH 03-13-2025
  • SAR 01-08-2025
  • Dividend Yield
  • NYXH N/A
  • SAR 12.83%
  • EPS Growth
  • NYXH N/A
  • SAR 33.28
  • EPS
  • NYXH N/A
  • SAR 2.49
  • Revenue
  • NYXH $5,668,079.00
  • SAR $154,793,533.00
  • Revenue This Year
  • NYXH $22.93
  • SAR $6.01
  • Revenue Next Year
  • NYXH $411.04
  • SAR N/A
  • P/E Ratio
  • NYXH N/A
  • SAR $10.41
  • Revenue Growth
  • NYXH 32.65
  • SAR 11.52
  • 52 Week Low
  • NYXH $6.76
  • SAR $21.56
  • 52 Week High
  • NYXH $20.00
  • SAR $26.49
  • Technical
  • Relative Strength Index (RSI)
  • NYXH 51.74
  • SAR 66.99
  • Support Level
  • NYXH $10.47
  • SAR $25.25
  • Resistance Level
  • NYXH $10.92
  • SAR $25.76
  • Average True Range (ATR)
  • NYXH 0.41
  • SAR 0.33
  • MACD
  • NYXH -0.11
  • SAR 0.06
  • Stochastic Oscillator
  • NYXH 4.61
  • SAR 97.71

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

About SAR Saratoga Investment Corp New

Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.

Share on Social Networks: